石四药集团于国家集采接续采购中共45个品种的产品拟中标

Core Viewpoint - The company, 石四药集团, announced that it is expected to win bids for 45 products in the upcoming national centralized procurement scheduled for February 10, 2026, which is anticipated to have a positive impact on its business [1] Group 1: Product Categories - The 45 products cover various therapeutic areas including anti-infection, cardiovascular system, respiratory system, digestive system, and nervous system [1]